Login
Business
Clinical
Regulatory
Research
Profiles
Grand Rounds
PEER REVIEWS
ARCHIVES
SUBSCRIBE
CONTACT US
ADVERTISE
EDITORIAL CALENDAR
EVENTS
Spark Therapeutics
View Related Slideshows
Improved Sightlines
Jan 23, 2018 at 11:02 am
by
admin
FDA Approves Novel Gene Therapy In mid-December, the U.S. Food & Drug Administration announced approval of Luxturna (voretigene neparvovec-rzyl), the first directly admin....
Read More
RECENT HEADLINES
UAMS Receives $2.9 Million NIH Grant to Study Virus that Can Trigger Cancers
UAMS Invests Corey O. Montgomery, M.D., in Chair in Orthopaedic Oncology
WRH Surgery Clinic Welcomes New Provider
News Software by Bondware